Application Nr Approved Date Route Status External Links
NDA202611 2012-06-28 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Myrbetriq® Is A Beta-3 Adrenergic Agonist Indicated For The Treatment Of Overactive Bladder (oab) With Symptoms Of Urge Urinary Incontinence, Urgency, And Urinary Frequency. Myrbetriq® Is A Beta-3 Adrenergic Agonist Indicated For The Treatment Of Overactive Bladder (oab) With Symptoms Of Urge Urinary Incontinence, Urgency, And Urinary Frequency (1).

All Formulated Excipients (5 Total)

Name Structure Kind Function Status
1. Polyethylene Glycols POLYETHYLENE GLYCOLS Unresolved
2. Butylated Hydroxytoluene BUTYLATED HYDROXYTOLUENE Molecular
3. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
4. Hypromelloses HYPROMELLOSES Unresolved
5. Ferric Oxide Yellow FERRIC OXIDE YELLOW Molecular

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mirabegron MIRABEGRON ZINC1996784

Comments